New findings that snakes thrive without the hunger hormone ghrelin suggest future obesity drugs could safely mute hunger at its source, complementing today’s satiety‑boosting therapies.

Fast functional testing of genetic variants, from newborn genomes to disease models like zebrafish, is transforming ambiguous DNA findings into confident, real‑time treatment decisions.

Senators Hawley and Warren want to break up vertically integrated healthcare conglomerates. History shows, however, how hard a task this will be to accomplish.

It’s conspicuous that HHS refuses to review Moderna’s application for regulatory approval of an mRNA-based flu vaccine while it prioritizes research on debunked theories.

Tobacco smoking, alcohol consumption and infections were the three leading causes of preventable cancers according to research by the World Health Organization.

Independent of FDA’s enhanced oversight, it’s clear that DTC promotion of weight loss drugs is having a moment, as companies go all in in pursuit of uptake expansion.

A genetics‑guided drug, compound 6, targets CARD9 to subtly calm gut inflammation in Crohn’s disease, pointing to safer, longer‑lasting, precision treatments.

mRNA CAR T therapy Descartes‑08 targets BCMA‑positive plasma cells and delivers year‑long symptom relief in myasthenia gravis after a brief course, signaling a new era of durable treatment.

New twin‑study research finds that, after removing deaths from accidents and infections, genes account for about 50% of human lifespan, highlighting a major inherited component of longevity.

Critics warn that health savings accounts aren’t the fix some suggest they may be. The financial risks for patients are particularly large should they become ill.